Confounding in Veterinary Studies: Identification and Control
By Dr. Zubair Khalid, DVM, MS, PhD ·

Key Takeaways
- Confounding occurs when an extraneous variable is associated with both the exposure and the outcome, distorting the true exposure-outcome relationship. For instance, age is a common confounder in canine vaccination studies, as puppies receive vaccines at specific ages and are also more susceptible to infectious diseases.
- A variable is a confounder if it is associated with the exposure, an independent risk factor for the outcome, and not on the causal pathway between exposure and outcome. For example, body condition score is a mediator, not a confounder, when studying the effect of diet on clinical disease.
- Design-based strategies like randomization, restriction, and matching are crucial for controlling confounding before data collection. Randomization is the most powerful, breaking associations between exposure and all confounders, while restriction limits the study population to a single level of a confounder.
- Analysis-based control methods, including stratification and multivariable regression, adjust for measured confounders. Stratification divides data into strata of the confounder, while multivariable regression statistically adjusts for multiple covariates, requiring careful model specification.
- Confounding by indication is prevalent in observational treatment studies, where disease severity or prognosis influences treatment assignment. This can lead to biased treatment effect estimates, as seen in studies where sicker animals may systematically receive a new therapeutic agent.
- Effect modification, where the effect of an exposure differs across levels of a third variable (e.g., parasiticide efficacy varying between lambs and ewes), is distinct from confounding and should be reported as stratum-specific estimates rather than adjusted away.
Confounding is a central threat to valid inference in veterinary epidemiological research. It arises when an extraneous variable is associated with both the exposure under study and the outcome of interest, creating a distortion in the estimated exposure-outcome relationship. This article provides a structured account of how confounding operates in veterinary studies, how it is distinguished from related concepts such as effect modification, and which design-based and analysis-based strategies are available for its control. It is written for veterinary researchers, graduate students in epidemiology, and clinicians engaged in critical appraisal of the literature.
The practical questions addressed here are concrete. When does a variable qualify as a confounder instead of a mere correlate? How should a researcher decide between stratification, multivariable adjustment, and matching? When is confounding by indication unavoidable in observational clinical data? The article answers these questions with reference to veterinary examples across companion animal, livestock, and wildlife populations, and it draws on established epidemiological principles as set out in the CDC principles of epidemiology in public health practice.
At a Glance
| Parameter | Definition or decision | Clinical or research relevance |
|---|---|---|
| Confounder | Variable associated with exposure and outcome, not on the causal pathway | Failure to control produces biased effect estimates |
| Confounding by indication | Disease severity or prognosis drives treatment assignment | Common in observational treatment studies |
| Directed acyclic graph (DAG) | Causal diagram mapping assumed relationships | Identifies minimal sufficient adjustment sets |
| Stratification | Analysis within strata of the confounder | Simple, transparent, limited by sample size |
| Multivariable regression | Statistical adjustment for multiple covariates | Standard approach, requires correct model specification |
| Matching | Selection of comparison subjects on confounder values | Used in case-control designs, cannot control unmeasured confounders |
| Effect modification | Effect of exposure differs across levels of a third variable | Distinct from confounding, should be reported, not adjusted away |
The Conceptual Basis of Confounding
A confounder is a variable that satisfies three conditions. It must be associated with the exposure in the source population. It must be an independent risk factor for the outcome, or a proxy for such a risk factor. And it must not lie on the causal pathway between exposure and outcome. A variable that is intermediate in the causal chain, such as body condition score when studying the effect of a dietary intervention on clinical disease, is not a confounder and should not be adjusted in the same manner.
The classic veterinary illustration involves age. In a study of the association between canine vaccination status and infectious disease, age is associated with vaccination because puppies receive primary courses at defined ages. Age is also strongly associated with infectious disease incidence. Age is not caused by vaccination. Age therefore confounds the crude association, and failure to adjust for it will distort the estimated vaccine effect.
Confounding is a property of the causal structure assumed by the investigator, also a statistical property of the data. Two variables may be correlated in a dataset without one confounding the exposure-outcome relationship. The distinction matters because automated variable selection procedures, such as stepwise regression, cannot distinguish confounders from colliders or mediators. Directed acyclic graphs provide a formal language for representing the assumed causal structure and for identifying which variables require adjustment. The CDC principles of epidemiology in public health practice describe the underlying logic of causal inference and the role of adjustment in observational research.
Confounding versus Effect Modification
Confounding is a distortion to be removed. Effect modification is a biological or clinical phenomenon to be described. When the effect of an exposure on an outcome differs across levels of a third variable, that third variable is an effect modifier. For example, the effect of a parasiticide on weight gain may differ between growing lambs and adult ewes. The crude estimate obscures this difference, but the correct analytical response is not to adjust it away. It is to report stratum-specific estimates.
The two concepts are frequently confused because both involve a third variable. The distinction is operational. A confounder produces a biased estimate of a single underlying effect. An effect modifier indicates that no single effect exists. In practice, a variable can be both. Age may confound the association between a drug and an adverse outcome while also modifying the magnitude of the drug effect. The researcher must then decide whether to present adjusted overall estimates, stratum-specific estimates, or both.
Sources of Confounding in Veterinary Research
Confounding enters veterinary studies through several recurring pathways. Species, breed, age, sex, and management system are common confounders in production animal research. In dairy herds, for example, parity confounds the association between milk yield and disease risk because both yield and disease incidence increase with parity. In companion animal studies, breed confounds many associations because breed is associated with both genetic disease predisposition and owner-reported exposures such as diet or exercise.
Environmental and management factors are particularly important in livestock and wildlife studies. Herd-level variables such as stocking density, ventilation, and biosecurity practices are associated with both exposure and outcome in many infectious disease studies. In wildlife research, nutritional status and energetic condition frequently confound the association between contaminant exposure and mortality. A case-control study of harbor porpoises examined whether polychlorinated biphenyl (PCB) exposure increased the risk of infectious disease mortality. The investigators controlled for the effect of confounding factors, including the negative relationship between blubber PCB concentration and blubber mass, because animals in poor energetic condition had both higher lipid-normalized PCB concentrations and higher infectious disease mortality. The harbor porpoise PCB case-control study demonstrates how a biological confounder can be addressed through both statistical adjustment and standardization of the exposure measure.
Confounding by indication deserves separate mention because it is pervasive in clinical veterinary research. When treatment assignment is influenced by disease severity, prognosis, or owner-reported clinical status, the treatment effect estimate is distorted. Animals that receive a new therapeutic agent may be systematically sicker than those receiving a standard agent, or they may be healthier because owners seek care earlier. Neither direction can be assumed. The occupational chlorinated solvent exposure review notes that the inability to control for confounding factors, particularly smoking and mixed exposures, limited the interpretability of human studies. The same logic applies to veterinary clinical data where concurrent medications, comorbid conditions, and owner compliance are rarely measured with precision.
Identifying Confounders in Study Design
The most reliable approach to confounding control begins before data collection. Restriction limits the study population to a single level of a potential confounder, such as enrolling only primiparous cows or only dogs of a single breed. Restriction is simple and effective but reduces generalizability and may make recruitment impractical.
Matching selects comparison subjects with identical or similar values of the confounder. It is most commonly used in case-control studies, where the exposure distribution is compared between cases and controls within matched sets. Matching controls for the matched variables by design, but it introduces two costs. Matched variables cannot be examined as exposures, and the analysis must account for the matching to avoid overestimating precision. The CDC principles of epidemiology in public health practice provide the analytical framework for matched designs.
Randomization is the most powerful design-based control because it breaks the association between exposure and all confounders, measured or unmeasured, in expectation. Random allocation does not guarantee balance in any single study, particularly in small samples, but it provides the theoretical basis for causal inference that observational designs lack. Veterinary randomized trials are feasible for many clinical questions, yet they remain underused in some areas of the literature.
The Assessment Sequence for Confounding
The practical identification of confounding proceeds through a structured sequence that begins before data collection and continues through analysis. The first step is to construct a directed acyclic graph (DAG) for the research question. A DAG maps the presumed causal pathways from exposure to outcome and forces explicit decisions about which variables lie on causal paths, which are common causes of exposure and outcome, and which are consequences of the exposure or outcome. Variables that are common causes of exposure and outcome are confounders by definition. Variables that lie on the causal pathway from exposure to outcome are mediators and must not be adjusted. Variables that are consequences of the outcome, such as disease-induced changes in diet or body condition, are colliders and adjusting for them introduces selection bias.
The second step is to assess each candidate variable against three criteria. The variable must be associated with the exposure in the source population. It must be an independent risk factor for the outcome, or a proxy for such a risk factor. It must not lie on the causal pathway between exposure and outcome. A variable that meets the first two criteria but is a mediator should be excluded from adjustment. A variable that meets the first two criteria and is not a mediator is a confounder and should be controlled.
The third step is to evaluate the direction and magnitude of expected confounding. This requires subject-matter knowledge instead of statistical testing. For example, in a study of PCB exposure and infectious disease mortality in harbor porpoises, blubber mass was negatively correlated with PCB concentration and also reflected energetic status, which influenced mortality risk. The authors addressed this by standardizing blubber PCB concentrations to an optimal blubber mass, which reduced the odds ratio from 1.048 to 1.02 per mg/kg increase. This example illustrates that the magnitude of confounding can be substantial and that failure to control it can produce inflated effect estimates.
The fourth step is to decide whether confounding is likely to be positive or negative. Positive confounding exaggerates the true association, while negative confounding masks it. In occupational studies of diesel exhaust and lung cancer, smoking is a positive confounder because smoking is associated with employment in diesel-exposed occupations and is an independent cause of lung cancer. Studies that failed to control for smoking produced inflated risk estimates, while studies that controlled for smoking produced attenuated but still elevated risks. The direction of confounding should be stated explicitly in the analysis plan.
Control at the Design Stage
Design-based control prevents confounding from entering the data. Randomization is the most powerful method because it distributes both measured and unmeasured confounders across exposure groups in expectation. Randomization is feasible in clinical trials of veterinary therapeutics and in some field trials of nutritional interventions or vaccine efficacy. It is not feasible for most observational questions in veterinary medicine, including environmental exposure studies, production system comparisons, or wildlife disease investigations.
Restriction limits the study population to a single level of a confounder. A study of respiratory disease in feedlot cattle might restrict enrollment to a single breed, a single sex, or a narrow age range. Restriction eliminates confounding by the restricted variable but reduces generalizability and may make recruitment difficult. It is most useful when the confounder has few relevant levels and when the restricted population remains large enough for adequate statistical power.
Matching selects comparison subjects with the same or similar values of the confounder. Individual matching pairs each case with a control that shares age, sex, breed, or other characteriztics. Frequency matching selects controls so that the distribution of the confounder matches that of the cases. Matching is efficient for strong confounders such as age in cancer studies, but it has costs. Matched variables cannot be examined as risk factors, and overmatching on variables related to exposure but not outcome reduces precision without reducing confounding. In case-control studies, matching must be accounted for in the analysis with conditional logistic regression or stratified methods.
The choice among these methods depends on the research question, the feasibility of recruitment, and the number of confounders. The table below summarizes the selection criteria.
| Method | Best used when | Primary limitation | Analysis implication |
|---|---|---|---|
| Randomization | Exposure can be assigned ethically, clinical trials | Not feasible for observational questions | None beyond standard methods |
| Restriction | Confounder has few levels, narrow target population | Reduced generalizability, recruitment difficulty | Stratified analysis may still be needed |
| Individual matching | Strong confounder, small case series | Cannot study matched variables, overmatching risk | Conditional logistic regression |
| Frequency matching | Large study, several categorical confounders | Less precise than individual matching | Stratified or adjusted analysis |
Control at the Analysis Stage
Analysis-based control adjusts for confounders that were measured during data collection. Stratification divides the data into strata defined by confounder levels and computes exposure-outcome associations within each stratum. The stratum-specific estimates are then combined into a summary estimate, typically a Mantel-Haenszel adjusted odds ratio or risk ratio. Stratification is transparent and does not require assumptions about the functional form of the confounder-outcome relationship. It becomes unwieldy with multiple confounders or continuous confounders with many levels.
Multivariable regression models adjust for several confounders simultaneously. Logistic regression is standard for binary outcomes, Cox proportional hazards models for time-to-event outcomes, and linear regression for continuous outcomes. The model must include all identified confounders, but the decision to include a variable should be based on the DAG and subject-matter knowledge, not on stepwise selection or statistical significance. A variable that is a true confounder should remain in the model even if its p-value exceeds 0.05, because the goal is confounding control instead of prediction.
Propensity score methods summarize all measured confounders into a single score representing the probability of exposure given the covariates. The score can be used for matching, stratification, or as a covariate in the outcome model. Propensity scores are useful when the outcome is rare or when there are many confounders relative to the number of events. They do not control for unmeasured confounders, and they require careful assessment of overlap between exposure groups.
Residual and Unmeasured Confounding
Residual confounding occurs when a confounder is measured with error, categorized too coarsely, or omitted entirely. Misclassification of a confounder typically attenuates the ability to control for it, leaving some confounding in the adjusted estimate. For example, smoking in occupational studies is often measured as current, former, or never, which fails to capture pack-years and leaves substantial residual confounding. The same problem arises in veterinary studies when body condition score is used as a proxy for energetic status, or when age is categorized into broad bands.
Unmeasured confounding is a threat in every observational study. The review of chlorinated solvent exposure noted that many studies were limited by the inability to control for smoking and mixed occupational exposures. Sensitivity analyzes can quantify how strong an unmeasured confounder would need to be to explain away the observed association. These analyzes should be reported routinely, particularly for studies that claim a null result.
A Decision Tree for Confounding Control
The decision tree below structures the choice of control methods.
- Can the exposure be assigned ethically and practically? If yes, use randomization. If no, proceed.
- Are there a small number of strong confounders with few levels? If yes, consider restriction or matching at the design stage.
- Can all identified confounders be measured accurately? If yes, proceed to analysis-based control. If no, plan sensitivity analyzes for unmeasured confounding.
- Is the outcome rare or the number of events small relative to the number of confounders? If yes, consider propensity score methods. If no, use multivariable regression.
- Are there effect modifiers that require separate reporting? If yes, present stratum-specific estimates in addition to adjusted summary estimates.
A Checklist for Study Design
The following checklist should be completed before data collection begins.
- Construct a DAG and identify all common causes of exposure and outcome.
- Distinguish confounders from mediators and colliders.
- Specify the direction and expected magnitude of confounding for each identified confounder.
- Select design-based controls (randomization, restriction, matching) appropriate to the research question and species.
- Define measurement protocols for all confounders, including validation against a reference standard where available.
- Pre-specify the analysis model and the variables to be included.
- Plan sensitivity analyzes for unmeasured confounding.
- Document all decisions in the study protocol.
Species and production system alter several of these decisions. Wildlife studies often cannot measure confounders with the precision available in clinical settings, as illustrated by the harbor porpoise PCB study where blubber mass served as a proxy for energetic status. Production animal studies may have access to herd-level records that allow precise measurement of management confounders, but individual-level data may be sparse. Companion animal studies benefit from owner-reported histories, which introduce recall error that can produce residual confounding. The WOAH animal health surveillance standards and the CDC principles of epidemiology provide frameworks for documenting these decisions in surveillance and field investigation contexts.
Recognized Failure Modes and Early Detection
Confounding control fails in predictable ways. The most common failure is incomplete covariate measurement, where a variable known to distort the exposure-outcome relation is either not recorded or recorded with poor precision. In occupational studies of veterinary personnel, for example, mixed exposures to solvents, anesthetic gases, and particulate matter are difficult to separate, and failure to measure each component leaves the association between any single agent and health outcome ambiguous. Reviews of occupational solvent epidemiology have noted that small study size and inability to control for smoking and mixed exposures have limited the interpretability of the literature. Early detection requires a formal directed acyclic graph before data collection, with every backdoor path identified and the variables on that path specified in the data dictionary.
A second failure mode is adjustment for an intermediate variable. When a covariate lies on the causal pathway between exposure and outcome, conditioning on it removes part of the true effect and can induce collider stratification. The discriminating check is temporal ordering: if the covariate changes after exposure begins and before outcome occurs, it is likely an intermediate, not a confounder. Blubber mass in marine mammal studies illustrates the difficulty, because energetic status both influences PCB accumulation and predicts infectious disease mortality, so standardization to an optimal blubber mass was used to separate the exposure effect from the metabolic state.
A third failure is overadjustment, where the analyst includes variables that are proxies for the exposure itself or that are affected by the outcome. This attenuates estimates toward the null and produces confidence intervals that are misleadingly narrow. Detection relies on comparing the crude and adjusted estimates and examining whether the adjusted estimate changes in a direction inconsistent with the hypothesised confounding structure.
| Observation | Likely cause | Discriminating check |
|---|---|---|
| Adjusted estimate moves away from null unexpectedly | Collider stratification or adjustment for intermediate | Review directed acyclic graph, check temporal order of covariate and exposure |
| Confidence interval narrows markedly after adjustment | Overadjustment or inclusion of exposure proxy | Examine correlation matrix, test model with and without suspect covariate |
| Effect differs across strata of a third variable | Effect modification, not confounding | Test interaction term, report stratum-specific estimates |
| No change after adjustment despite known confounder | Poor measurement of confounder or misclassification | Assess sensitivity of estimate to confounder misclassification |
Common Errors and Corrective Action
Less experienced analysts often mistake effect modification for confounding. The distinction is operational: a confounder is balanced by adjustment, whereas an effect modifier changes the magnitude of the exposure effect across its levels. The corrective action is to test for interaction before deciding on adjustment. In tea flavonol epidemiology, conflicting results across populations were attributed to confounding by coronary risk factors associated with tea consumption, and the authors noted that the protective effect was inconsistent across cohorts. A student who adjusts for an effect modifier without testing interaction will report a single summary estimate that obscures clinically meaningful differences between subgroups.
A second common error is adjusting for every measured variable without a causal framework. This practice, sometimes called the kitchen sink approach, introduces variance inflation and can create associations where none exist. The corrective action is to specify the minimal sufficient adjustment set from the directed acyclic graph before analysis and to restrict adjustment to that set.
A third error is ignoring the pregnancy signal or its veterinary analogue, the healthy participant effect. In reproductive epidemiology, studies that failed to account for the fact that healthy pregnancies are more likely to be recognized and followed produced inconsistent results for caffeine and spontaneous abortion. The veterinary parallel occurs in production medicine, where healthy herds are more likely to be enrolled in surveillance programs. The corrective action is to design the study so that the selection mechanism is explicit and to analyze with methods that condition on the selection variable.
Limitations of Current Evidence
The veterinary confounding literature is thinner than the human literature, and much of the methodological guidance is borrowed from human epidemiology. The CDC principles of epidemiology provide the standard framework for confounding identification and control, but they are written for human populations and do not address species-specific issues such as multiple litters, culling practices, or herd-level clustering. The WOAH terrestrial animal health standards address surveillance design but do not provide analytical guidance for confounding control.
Expert opinion differs on the value of sensitivity analysis for unmeasured confounding. Some authors advocate routine quantitative bias analysis, while others argue that the assumptions required are too speculative to be useful. The evidence base is also limited by the predominance of small studies. Reviews of diesel exhaust epidemiology noted that negative studies frequently suffered from insufficient latency and positive studies often failed to control for smoking, and the same pattern appears in veterinary occupational studies. The lack of prospective biomarker studies, identified as a need in solvent epidemiology, applies equally to veterinary exposures.
Referral, Consultation, and Reporting
Most confounding problems are resolved within the study team, but specific circumstances warrant escalation. When the exposure-outcome relation is central to a regulatory decision, such as a withdrawal period or a residue tolerance, consult a veterinary epidemiologist with experience in the relevant production system. The WOAH terrestrial animal health code provides the framework for surveillance and trade-related decisions, and deviations from standard methods should be justified against that framework.
Laboratory involvement is warranted when exposure measurement is imprecise. Blubber PCB measurements in the harbour porpoise study required standardization to lipid content, and similar issues arise with serum concentrations of fat-soluble compounds. A laboratory with validated analytical methods and quality control procedures should be consulted before the study begins, not after data collection.
Regulatory reporting is required when the study involves notifiable disease, unusual mortality events, or potential zoonotic exposure. The WOAH animal health surveillance standards describe the reporting obligations for member countries, and the AVMA practice resources provide guidance on professional obligations in the United States. When a study reveals an unexpected occupational health risk in veterinary personnel, the institutional health and safety officer should be informed, and the study protocol should include a mechanism for this escalation.
Frequently Asked Questions
How Do I Decide Whether to Control for a Potential Confounder When Resources Are Limited?
Prioritize confounders with strong, documented associations with both exposure and outcome in your target population. Age, sex, and breed are almost always worth measuring because they predict many outcomes and exposures in veterinary medicine. When laboratory assays or specialised examinations are unaffordable, substitute cheaper proxies with known validity, such as body condition score for energetic status or housing density for infectious pressure. If a confounder cannot be measured, consider restricting the study population to a single stratum of that variable, for example enrolling only adult animals, which removes its influence at the cost of generalizability. Document every unmeasured candidate and justify its omission in the limitations section, because reviewers will otherwise assume oversight.
What Should I Do When the Ideal Measurement Instrument Is Unavailable in the Field?
Use the most valid instrument that is practically feasible and record its limitations explicitly. Blubber thickness, for instance, may stand in for direct lipid measurement when necropsy material is limited, but the resulting exposure estimates carry additional error. When a substitute is used, perform a sensitivity analysis in which the confounder is adjusted using plausible ranges of the measurement error. If the exposure-outcome association remains stable across those ranges, the conclusion is more defensible. Where no substitute exists, consider changing the study design, for example a matched case-control approach that balances the unmeasured variable across groups. State the substitute and its validation status in the methods so readers can judge the residual risk of confounding.
How Does Confounding Control Differ in Wildlife and Free-Ranging Populations?
Wildlife studies rarely permit randomisation, repeated sampling, or complete outcome ascertainment, so confounding control depends heavily on design choices. Case-control designs are common because they work with opportunistic sampling, as illustrated by the use of stranding data to assess infectious disease mortality risk in harbour porpoises, where physical trauma cases served as controls to represent population exposure prevalence. Energetic status and age are frequent confounders in wildlife because they influence both contaminant accumulation and disease susceptibility. Blubber mass, body condition, and season must be measured and adjusted, often by standardizing exposure to an optimal tissue mass. Capture methods can introduce selection bias that mimics confounding, so document sampling frames carefully and consult surveillance standards from bodies such as the World Organization for Animal Health when designing population-based wildlife monitoring.
What Records Should I Keep to Support Confounding Control During Peer Review?
Maintain a pre-specified analysis plan that lists candidate confounders, their measurement methods, and the criteria for inclusion in adjusted models. Record the date of every measurement, the instrument used, and the identity of the person who performed it. Keep raw data files and analysis scripts so that reviewers can reproduce each modeling step. Document any variable that was considered but excluded, with the reason for exclusion. For field studies, retain enrollment logs that show how many eligible animals were missed and why, because non-participation can correlate with exposure and outcome. These records allow reviewers to distinguish deliberate analytic choices from post hoc data dredging and strengthen the credibility of the reported adjusted estimates.
How Should I Explain Confounding to a Client or Supervisor Who Wants a Simple Answer?
Explain that confounding means a third factor is associated with both the suspected cause and the observed effect, creating a misleading impression of a direct link. Use a concrete veterinary example, such as older dogs being both more likely to receive certain diets and more likely to develop dental disease, so the diet appears harmful when age is the real driver. State that the study design or statistical analysis can separate the effect of the third factor from the effect of the exposure. Avoid promising certainty, because unmeasured confounders can never be fully excluded, as reviews of occupational and nutritional epidemiology have repeatedly shown. Offer the practical implication, for example whether a change in management is warranted given the strength of the evidence.
When Is It Acceptable to Report an Unadjusted Estimate Alongside the Adjusted One?
Reporting both estimates is acceptable and often informative when the crude and adjusted values differ meaningfully, because that difference demonstrates the magnitude of confounding. Present the crude estimate first, then the adjusted estimate with the confounders listed and the modeling approach specified. If the association disappears after adjustment, state that explicitly and interpret the null result as evidence that the crude association was confounded. If the association persists, note that residual confounding by unmeasured variables remains possible. This practice is particularly valuable in observational studies where the exposure cannot be randomised, as seen in assessments of environmental exposures where smoking and mixed occupational exposures have historically obscured causal inference. Always report confidence intervals for both estimates so readers can judge precision.
Related Clinical & Scientific Guides
- Evaluating Veterinary Surveillance System Attributes
- Network Analysis for Infectious Disease Spread in Animal Populations
- Randomized Controlled Trials in Veterinary Field Settings
References and Further Reading
- Potential health effects of occupational chlorinated solvent exposure.. 2006.
- Lung cancer and diesel exhaust: a review.. 1986.
- Critical review of the human data on short-term nitrogen dioxide (NO2) exposures: evidence for NO2 no-effect levels.. 2009.
- The risk of infection from polychlorinated biphenyl exposure in the harbor porpoise (Phocoena phocoena): a case-control approach.. 2006.
- Tea flavonols in cardiovascular disease and cancer epidemiology.. 1999.
- Evaluation of the reproductive and developmental risks of caffeine.. 2011.
- WOAH Animal Health Surveillance Standards. WOAH.
- CDC Principles of Epidemiology in Public Health Practice. CDC.
- MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
Related Articles
- Case-Control Studies in Veterinary Epidemiology: Selection and Analysis
- Cluster Sampling in Veterinary Field Studies
- Understanding Bias in Veterinary Epidemiological Studies
- Understanding Ecological Studies in Veterinary Epidemiology
- Cohort Studies in Veterinary Medicine: Design and Analysis
This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.